REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,638,929 | -36.2% | 2,051,000 | -15.7% | 0.02% | -40.0% |
| Q2 2023 | $2,568,957 | -59.0% | 2,432,000 | -55.3% | 0.03% | -44.4% |
| Q3 2021 | $6,268,000 | +83.5% | 5,445,000 | +86.6% | 0.05% | +107.7% |
| Q2 2021 | $3,416,000 | +3.9% | 2,918,000 | 0.0% | 0.03% | -7.1% |
| Q1 2021 | $3,289,000 | – | 2,918,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |